Stock Information
Xeris Biopharma Holdings Inc (XERS)
Ticker Symbol: XERS
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,393.24 mil
Piotroski score: 5
PE Ratio: 122.06
EPS (TTM): 0.06
Revenue (TTM): $1.77 M
Dividend Yield: N/A
ROE: 99.74%
Latest News
-
Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity
Thu, Aug 20, 2026 12:50 PM
-
Barclays Maintains Overweight on Xeris Biopharma Holdings, Raises Price Target to $12
Thu, Aug 20, 2026 11:35 AM
Key Financials
Financial data not available